MAPT and Alzheimer disease: In that study the interference with TLR-4 attenuated all the negative events associated with the AD model phenotype: Aβ burden, neuroinflammation, tau hyperphosphorylation, synaptic degeneration, hippocampal neuronal loss, and memory impairment (Ding et al., 2021).